Skip to content
Use caution Medical device recall · FDA · Published June 7, 2021

Medtronic Endurant II Stent Graft System Recall: Radiopaque Marker Detaches During

Medtronic recalls Endurant II stent graft systems with specific model numbers due to risk of radiopaque marker detaching during deployment, potentially causing complications.

🇺🇸 FDA recall #Z-2135-2021Medical deviceMedtronic ›
Take action

Contact the company

Recalling firmMedtronic Vascular, Inc.3850 Brickway Blvd · Santa Rosa, CA 95403-8223
✎ GovInfoNow plain-language explainer

What happened, in plain English

Medtronic is recalling specific Endurant II stent graft systems because the radiopaque marker can detach during deployment. This could lead to complications if the marker becomes dislodged and is not properly visible during procedures. Read more at govinfonow.com/recall/62374-medtronic-endurant-ii-stent-graft-system-recall-radiopaque-marker-detaches.

Source Summary by GovInfoNow · govinfonow.com/recall/62374-medtronic-endurant-ii-stent-graft-system-recall-radiopaque-marker-detaches · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2135-2021

Cite this page

“Medtronic Endurant II Stent Graft System Recall: Radiopaque Marker Detaches During.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62374-medtronic-endurant-ii-stent-graft-system-recall-radiopaque-marker-detaches. Based on FDA recall #Z-2135-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2135-2021%22&limit=1).

Why it’s dangerous

During stent graft deployment, the radiopaque marker bond can detach from the distal end of the graft cover. This may cause the marker to become dislodged, making it difficult to track the device during procedures and potentially leading to complications.

Who’s affected

Patients who have received the recalled Endurant II stent graft systems for abdominal aortic or aortoiliac aneurysms are affected. Medical professionals using these systems during procedures are at risk if the marker detaches.

How to tell if you have this one

Check for model numbers: ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, or ETUF3614C102E. These systems were sold with specific serial numbers listed in the recall notice.

  • Brand
    Medtronic
  • Product
    Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S.: GA, MA, MD, NY, SC, TX, WA, and WV O.U.S.: Argentina, Australia, Germany, Greece, Israel, Italy, Netherlands, Poland, South Africa, Spain, Switzerland and United Kingdom.
Recall numberProduct, codes & lotsQuantity
Z-2135-2021Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.; Endurant II Stent Graft System: Model (REF): ETCF3636C49EE GTIN: 00763000099626 Serial Numbers: V29778214; V29778215; Model (REF): ETUF3214C102EE GTIN: 00643169780958 Serial Numbers: V29775791; V29775792; V29775793; V29775794; V29775795; Model (REF): ETBF3216C166EE GTIN: 00763000099626 Serial Numbers: V29778214; V29778215; Model (REF): ETUF3614C102E GTIN: 00643169232631 Serial Numbers: V29781886 V29781883 V29781889 V29781887 V29781890 V29781891 V2978188218 devices
Z-2136-2021Medtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.; Endurant IIs Stent Graft System: Model (REF):ESBF3214C103E GTIN: 00643169439962 Serial Numbers: V29780773; V29780771; V29780759; Model (REF): ESBF3614C103EE GTIN: 00643169780460 Serial Numbers: V29781932; V29781933; V29781934; V29781935; V29781936; V29781937; V29781938; V29781939; V29781940; V29781941; V29781942; V29781943; V29781944; V29781945; V29781946; V29781947; V29781948; V29781951;21 devices
Based on the official FDA remedy

What to do — step by step

  1. Check Product Model

    Identify your stent graft system model number by checking the product label or documentation.

  2. Contact Medtronic

    Reach out to Medtronic directly to confirm if your specific model is recalled and get instructions for next steps.

Where it went and when

Where it was distributed

Distributed in 8 states, and outside the U.S.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: yesWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: yesNYRhode Island: not listedRIMassachusetts: yesMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: yesWVVirginia: not listedVAMaryland: yesMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: yesSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: yesGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “U.S.: GA, MA, MD, NY, SC, TX, WA, and WV O.U.S.: Argentina, Australia, Germany, Greece, Israel, Italy, Netherlands, Poland, South Africa, Spain, Switzerland and United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Georgia, Maryland, Massachusetts, New York, South Carolina, Texas, Washington, West Virginia.

Recall timeline

FDA published this recall 58 days after the firm started it.

1. Firm started the recall: Jun 7, 202112. FDA classified it Class II: Jul 23, 202123. Published in FDA’s Enforcement Report: Aug 4, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2135-2021 (June 7, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2135-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA